Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
Sonoko HaradaKazuhisa Takahashi

Abstract

Treatment guidelines for asthma recommend step-down therapy for well-controlled asthma patients. However, the precise strategy for step-down therapy has not been well defined. We investigated whether well-controlled patients with mild persistent asthma can tolerate a step-down therapy of either a reduced dose of inhaled corticosteroid (ICS) or a switch to a leukotriene receptor antagonist (LTRA), pranlukast hydrate. We recruited 40 adult patients with mild persistent asthma who were well-controlled for at least 3 months with a low-dose ICS therapy. The patients were randomly assigned to either an ICS dose reduction or a switch to pranlukast for 6 months. FeNO levels in the pranlukast group were significantly increased over that in the ICS group. There were no significant differences between the two groups for lung function, FOT, at the endpoint. The percentage of patients with controlled asthma was 72.2% in the pranlukast group and 90% in the ICS group. No statistically significant difference between the two groups in the percentages of patients with treatment failure was observed. Patients with mild persistent asthma that is well-controlled by a low dose of ICS can be switched to pranlukast safely for at least 6 months. Howeve...Continue Reading

References

May 1, 1995·International Archives of Allergy and Immunology·P H HowarthS T Holgate
Jan 15, 1994·Lancet·S A KharitonovP J Barnes
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·S A KharitonovP J Barnes
May 1, 1997·The Journal of Allergy and Clinical Immunology·H KanazawaJ Yoshikawa
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·H BisgaardJ A Oj
Jun 16, 2000·The Journal of Allergy and Clinical Immunology·E R BleeckerK A Rickard
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·R A DweikS C Erzurum
Mar 10, 2001·The Journal of Allergy and Clinical Immunology·W BusseUNKNOWN Fluticasone Proprionate Clinical Research Study Group
Mar 21, 2001·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·K YamauchiH Inoue
May 15, 2002·Mayo Clinic Proceedings·Eli O MeltzerUNKNOWN Fluticasone Propionate Clinical Research Study Group
Jun 14, 2002·The Journal of Allergy and Clinical Immunology·Stephen J FowlerBrian J Lipworth
Dec 3, 2003·American Journal of Respiratory and Critical Care Medicine·Andrew D SmithD Robin Taylor
Dec 23, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Matthew MasoliRichard Beasley
Apr 13, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Matthew MasoliRichard Beasley
May 26, 2005·The New England Journal of Medicine·Andrew D SmithD Robin Taylor
Jul 13, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M W H PijnenburgJ C De Jongste
Mar 3, 2006·European Journal of Pharmacology·Sven-Erik Dahlén
Mar 9, 2006·The Journal of Allergy and Clinical Immunology·Eric D BatemanMarie Duggan
Oct 13, 2006·The Journal of Allergy and Clinical Immunology·Yoshiko Ogawa, William J Calhoun
Dec 5, 2006·BMC Pulmonary Medicine·Erkka Valovirta, Ruby Pawankar
Apr 26, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F BraidoG W Canonica
May 15, 2007·American Journal of Respiratory and Critical Care Medicine·Dominick E ShawIan D Pavord
May 18, 2007·The New England Journal of Medicine·UNKNOWN American Lung Association Asthma Clinical Research CentersRobert A Wise
Oct 22, 2008·American Journal of Respiratory and Critical Care Medicine·Johan C de JongsteEugenio Baraldi
May 1, 2010·Respiratory Medicine·Helen K ReddelChristine R Jenkins
May 6, 2011·The New England Journal of Medicine·David PriceIan Harvey
May 6, 2011·The New England Journal of Medicine·Sven-Erik DahlénJeffrey M Drazen
Oct 25, 2012·Allergology International : Official Journal of the Japanese Society of Allergology·Masayuki HojoHaruhito Sugiyama
Jan 1, 2013·Allergology International : Official Journal of the Japanese Society of Allergology·Masayuki HojoHaruhito Sugiyama

❮ Previous
Next ❯

Citations

Mar 17, 2017·The Cochrane Database of Systematic Reviews·Bhupendrasinh F ChauhanFrancine M Ducharme
Jul 5, 2018·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Jonathan A Bernstein, Lyndon Mansfield
May 23, 2020·The European Respiratory Journal·Anh Tuan Dinh-Xuan, Guy Brusselle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
M Bradley DrummondAmerican Lung Association Asthma Clinical Research Center Research Group
The Cochrane Database of Systematic Reviews
Bhupendrasinh F ChauhanFrancine M Ducharme
Allergology International : Official Journal of the Japanese Society of Allergology
Naomi TsurikisawaKazuo Akiyama
© 2021 Meta ULC. All rights reserved